Biobin Injection: Uses, Strengths, Benefits, Side Effects & FAQs

Biobin Injection – Product Description

Biobin Injection is a cytarabine-based prescription medicine used in the treatment of certain blood cancers. Cytarabine belongs to a class of medicines known as antimetabolites. It works by interfering with DNA synthesis, helping inhibit the growth and multiplication of cancer cells. Treatment decisions depend on the patient's diagnosis, clinical condition and the prescribed chemotherapy protocol.

Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information to support healthcare professionals, distributors and prospective business partners seeking reliable medicine-related information. Please verify the specific Biobin product, manufacturer and marketing authorization details before publication or commercial distribution.

Biobin Injection Strengths

Biobin Injection is listed in pharmaceutical references in different strengths, including:

Biobin 100 mg Injection

Biobin 500 mg Injection

Biobin 1 g Injection

Availability, concentration, vial size and formulation may vary by manufacturer and market. Confirm the exact strength and pack information against the relevant product label before ordering or prescribing.

Uses and Potential Benefits of Biobin Injection

Biobin Injection may be prescribed by an oncology specialist for certain haematological malignancies, depending on the treatment protocol. Its active ingredient, cytarabine, is used in chemotherapy regimens for conditions such as acute myeloid leukaemia (AML) and other selected leukaemias.

The medicine interferes with the replication of cancer cells. It may be administered alone or alongside other anticancer medicines as part of a specialist-supervised treatment plan.

Important: Biobin Injection is a prescription chemotherapy medicine, not a general-purpose treatment. Its suitability, dose, route of administration and treatment duration must be determined by a qualified healthcare professional.

Biobin Injection Side Effects and Safety Precautions

Like other chemotherapy medicines, cytarabine can cause side effects. These may include:

Nausea and vomiting

Loss of appetite

Diarrhoea

Mouth sores or ulcers

Skin rash

Hair thinning or hair loss

Reduced blood cell counts

Low white blood cell and platelet counts can increase the risk of serious infections and bleeding. Seek urgent medical advice for fever, unusual bruising, persistent bleeding or other concerning symptoms.

Patients should inform their healthcare team about existing medical conditions, current medicines, allergies and pregnancy or breastfeeding considerations. Regular blood tests and clinical monitoring are essential during treatment. Biobin Injection must only be administered by appropriately trained healthcare professionals according to the applicable prescribing information.

Frequently Asked Questions (FAQs)

1. What is Biobin Injection used for?

Biobin Injection contains cytarabine, a chemotherapy medicine used to treat certain blood cancers, including selected forms of leukaemia.

2. What strengths of Biobin Injection are available?

Product listings include 100 mg, 500 mg and 1 g presentations. Confirm current availability and exact packaging with the relevant supplier.

3. What are the common side effects of Biobin Injection?

Possible side effects include nausea, vomiting, diarrhoea, mouth ulcers, rash and hair loss. Reduced blood cell counts are an important safety concern.

4. Can Biobin Injection be used without a prescription?

No. It requires specialist medical supervision and must be used only as prescribed.

5. How can I obtain accurate product information?

Contact Cordium Pharmaceuticals Pvt Ltd for verified product documentation, subject to its role as the relevant supplier or authorized distributor.

Important Medical Disclaimer

This webpage is for general informational purposes only and does not replace professional medical advice, diagnosis or treatment. Product indications, strengths and availability must be verified against approved prescribing information in the relevant country.